Home › Funds › Palo Alto Investors LP › BCAX
Palo Alto Investors LP position in BCAX
BICARA THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 689,344 shares of BCAX (BICARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.8M, representing 1.91% of its reported portfolio and ranking #15 among its reported holdings. Palo Alto Investors LP has disclosed BCAX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's BCAX position evolved
Palo Alto Investors LP first disclosed a stake in BCAX in Q4 2025 at 298,575 shares (US$5.0M). The position peaked in Q2 2026 at 550,408 shares, worth US$16.3M. Across 4 filings, Palo Alto Investors LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 689,344 shares valued at US$12.8M — an increase of 138,936 shares quarter over quarter.. Notable position changes include a 84% increase in Q1 2026 (shares rose 49% over the following quarter), a 25% increase in Q3 2026 (shares fell 48% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 298.57K | $5.03M | New |
| Q1 2026 | 550.41K | $10.95M | Add |
| Q2 2026 | 550.41K | $16.34M | Hold |
| Q3 2026 | 689.34K | $12.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCAX and 13F data
BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$135.0M), Vestal Point Capital, LP (US$102.8M), Siren, L.L.C. (US$102.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCAX
- RA CAPITAL MANAGEMENT, L.P. 7.26M sh · $135.03M · Q3 2026
- Vestal Point Capital, LP 5.53M sh · $102.82M · Q3 2026
- Siren, L.L.C. 5.50M sh · $102.41M · Q3 2026
- Deep Track Capital, LP 4.10M sh · $76.30M · Q3 2026
- TPG GP A, LLC 3.01M sh · $56.02M · Q3 2026
- Red Tree Management, LLC 2.92M sh · $54.35M · Q3 2026
- Omega Fund Management, LLC 1.76M sh · $32.75M · Q3 2026
- Jones Hill Capital LP 1.06M sh · $19.81M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 668.38K sh · $12.44M · Q3 2026
- Aisling Capital Management LP 548.92K sh · $10.22M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 427.88K sh · $7.96M · Q3 2026
- DAFNA Capital Management LLC 299.95K sh · $5.58M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held BCAX?
Palo Alto Investors LP has disclosed BCAX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Palo Alto Investors LP's current position in BCAX?
As of Q3 2026, Palo Alto Investors LP holds 689.34K shares of BCAX (BICARA THERAPEUTICS INC), valued at $12.83M, representing 1.91% of its reported portfolio and ranking #15.
Has Palo Alto Investors LP been buying or selling BCAX?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in BCAX. The position peaked in Q2 2026 at 550.41K shares.
Which other funds hold BCAX?
Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Siren, L.L.C., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.